Abstract:Molecular farming is an advanced biotechnological breakthrough that utilises transgenic plants to behave as biofactories, manufacturing intricate and valuable medicinal proteins. This discipline combines modern genetic engineering techniques with conventional agricultural practices to facilitate the sustainable manufacturing of biopharmaceuticals, such as vaccines, monoclonal antibodies, and medicinal enzymes. Molecular farming enables the precise expression of therapeutic proteins by incorporating transgenes encoding these proteins into plant genomes. This process takes place in a regulated and biosafe environment, resulting in a cost-effective production system. This study explores advanced biotechnology methods that are now leading the field of molecular farming. The text emphasizes the utilization of cutting-edge gene-editing techniques, including Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9) and Transcription Activator-Like Effector Nucleases (TALENs). These methods not only enable accurate genomic insertions but also improve the efficiency of gene expression at the transcriptional and translational levels in plant cells. The use of both conventional viral vectors and novel synthetic vector systems is crucial in guaranteeing the steady integration, expression, and inheritance of transgenes. In addition, the study examines numerous crucial case studies where molecular farming has been effectively employed. These activities encompass the creation of antigens for vaccines targeting infectious illnesses such as influenza and HPV, as well as the manufacturing of monoclonal antibodies for the treatment of autoimmune disorders and malignancies. The conversation encompasses the process of bringing these drugs generated from plants into the commercial market. It explores the case of Elelyso, a treatment that replaces enzymes and is manufactured from carrot cells, which has successfully entered the market. Although molecular farming offers promise benefits, it faces several scientific and regulatory obstacles. Significant obstacles include the variation in protein expression levels across various plant hosts, challenges in extracting and purifying the proteins, and the requirement for substantial clinical studies to prove both safety and effectiveness. Furthermore, the regulations governing plant-derived medicines are intricate and strict, frequently necessitating tailored frameworks to accommodate the distinct characteristics of plant-based manufacturing systems. The report finishes by evaluating the future potential of molecular farming in relation to the changing requirements of the pharmaceutical business. The technology's intrinsic adaptability and capacity for expansion make it especially beneficial for quickly addressing health emergencies, such as pandemics, where conventional manufacturing methods may not be able to fulfill the immediate need for drugs. The ongoing progress in plant biotechnology, vector engineering, and regulatory science is expected to broaden the therapeutic uses of molecular farming, solidifying its role as a crucial component of cutting-edge drug production methods. Keywords- Molecular farming, plant derived pharmaceuticals.

Plant cell-based drug delivery enhances affordability of biologics

Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals

Molecular Farming: Biotechnological Approaches for Producing High-Value Plant-derived Pharmaceuticals

Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems

Improving Protein Quantity and Quality-The Next Level of Plant Molecular Farming

Plant-based biopharmaceutical engineering

Contributions of the international plant science community to the fight against infectious diseases in humans—part 2: Affordable drugs in edible plants for endemic and re‐emerging diseases

Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment

Biopharmaceutical production in plants: problems, solutions and opportunities

Integrating plant molecular farming and materials research for next-generation vaccines

Cellular engineering of plant cells for improved therapeutic protein production

Gene delivery strategies for therapeutic proteins production in plants: Emerging opportunities and challenges

Therapeutic recombinant protein production in plants: Challenges and opportunities

The production of biopharmaceuticals in plant systems

Green biotherapeutics: overcoming challenges in plant-based expression platforms

Therapeutically important proteins from in vitro plant tissue culture systems

Plant-made vaccine antigens and biopharmaceuticals

Recent advances in molecular farming using monocot plants

Green biofactories: recombinant protein production in plants

Plant-derived natural products for drug discovery: current approaches and prospects

Nanoscale Drug Delivery Systems: From Medicine to Agriculture